Professor Suzanne Garland (MBBS MD FRCPA FRANZCOG Ad Eundem FAChSHM) obtained her Bachelor of Medicine at the University of Melbourne in 1971, and subsequently worked as a Research Fellow at Harvard University. She commenced as Director of Clinical Microbiology and Infectious Diseases at the Royal Women’s Hospital in 1984. She is a regular advisor to the World Health Organisation on sexual and reproductive health infections, cervical cancer and human papillomavirus (HPV). Her laboratory is a Western Pacific WHO reference laboratory for HPV for the HPV Labnet.
Professor Garland has been a chief investigator for phase 3, clinical HPV vaccine trials for both the bivalent and quadrivalent vaccines and is currently measuring vaccine effectiveness post the vaccine rollout in Australia. Professor Garland was integral to the set up of the New Society Asia Oceania Research Organisation on Genital Infections and Neoplasia (AOGIN). She is the Inaugural and Past President of this Society and ongoing Board Advisor.
She currently is the Clinical Director of Microbiology and Infectious Diseases at The Royal Women’s Hospital and Senior Consultant in Microbiology at The Royal Children’s Hospital. Professor Suzanne Garland has published extensively in more than 500 peer-reviewed journals, and over 30 Chapter Books.